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Our skin routinely shields us from 
microbes, allergens, and other 
environmental assaults, a yeoman’s 
service we often take for granted—until 
that barrier is breached. In response 
to injury, be it a simple cut or a deep 
wound, keratinocytes, the cells that 
form the epidermal layer, proliferate 
and dispatch chemical messengers to 
enlist the healing services of immune 
cells. But new research shows that 
sometimes damaged skin can send 
the wrong message to its immune 
cell partners. Rather than recruiting 
immune cells to repair a wound, 
Raphael Kopan and colleagues report, 
defective skin can trigger a systemic, 
ultimately fatal immune response. 
As a self-renewing tissue with 
four distinct layers of specialized 
keratinocytes, the epidermis must 
constantly generate new cells to 
replace the many thousands that 
die each day. Both rejuvenation and 
wound repair require the support 
of a new pool of specialized cells, 
a process that is mediated by the 
Notch signaling pathway, an ancient 
intercellular communication system 
found in most multicellular animals. 
To remain healthy, skin must maintain 
a delicate balance between cell 
differentiation and growth. Interfering 
with differentiation—by impairing 
the Notch pathway, for example—can 
cause serious defects in the epidermal 
barrier and lead to inﬂammatory 
skin disorders like psoriasis or atopic 
dermatitis, a type of eczema.
The source of new cells comes from 
the innermost, basal, skin layer, which 
harbors a population of stem cells 
that continually divide to generate the 
cells that will eventually populate the 
other layers. Notch appears to operate 
in one way to suppress basal cell 
proliferation and promote keratinocyte 
differentiation, while using a different 
mode to ensure a dynamic equilibrium 
between differentiation and growth. 
To investigate Notch’s role in skin 
homeostasis and barrier formation, 
Kopan and colleagues used a protocol 
that removes multiple genes in the 
Notch pathway in keratinocytes 
during a narrow window of embryonic 
development in mice, when the blood 
system is forming. Most mice with no 
trace of Notch signaling in their skin 
developed chronic barrier formation 
defects akin to those seen in atopic 
dermatitis, and died about three weeks 
after birth. They also had extremely 
high levels of B cells, the white blood 
cells that produce antibodies to ﬁght 
infection.
Paralleling the loss of Notch 
signaling, the researchers saw an 
increase in the expression of a cytokine 
called thymic stromal lymphopoietin 
(TSLP), in direct proportion to the 
severity of defects in cell differentiation 
and barrier formation. The spike 
in TSLP levels in turn triggered an 
abnormal expansion of pre- and 
immature B cells in peripheral tissues 
(B cell development in normal 
embryos is restricted to the fetal liver), 
leading to dangerously high levels 
of B cells, a condition known as B-
lymphoproliferative disorder (B-LPD). 
In severe cases, the B cells ultimately 
inﬁltrate several organs in the mice, 
which results in death. 
TSLP, which has been implicated 
in atopic dermatitis, can stimulate the 
development of the fetal pre-B cells 
(but not adult pre-B cells) in test tubes. 
This study conﬁrms that exposure to 
high levels of TSLP during embryonic 
development can trigger a massive 
expansion of pre- and immature B 
cells, causing B-LPD and death. The 
ﬁnding that localized skin defects can 
cause a fatal systemic disease reveals 
a surprising, complex interaction 
between the immune system and the 
skin, and suggests many new questions 
to explore. Kopan and colleagues 
want to know, for example, how 
keratinocytes detect the severity of skin 
damage and translate this information 
into TSLP output. With a better 
understanding of the mechanisms 
underlying this skin–immune system 
connection, investigators may be able 
to develop new therapies to treat a 
wide range of incurable autoimmune-
related skin disorders, including 
atopic dermatitis, an often debilitating 
condition that commonly affects 
children.
Demehri S, Liu Z, Lee J, Lin M-H, Crosby SD, 
et al. (2008) Notch-deﬁcient skin induces 
a lethal systemic B-lymphoproliferative 
disorder by secreting TSLP, a sentinel for 
epidermal integrity. doi:10.1371/journal.
pbio.0060123
doi:10.1371/journal.pbio.0060133.g001
Dramatic expansion of pre- and immature 
B cells in peripheral blood is the hallmark 
of B-lymphoproliferative disorder, caused 
by defective skin differentiation seen in the 
newborn mice lacking Notch signaling in 
their skin. The inset shows a lymphoblast.